Eli Lilly to acquire Seattle-area vaccine maker for $1.5 billion - The Seattle Times

Eli Lilly to acquire Seattle-area vaccine maker for $1.5 billion The Seattle Times Healthy Returns: Eli Lilly makes a new push into vaccines – here’s what to know CNBC Lilly Goes on $20 Billion Buying Spree as Company Seeks Next Act Bloomberg.com Lilly announces three acquisitions to build infectious disease portfolio | Eli Lilly and Company investor.lilly.com Three vaccine biotechs to be bought by Lilly for up to $3.8B Endpoints News